PBM

Psyence Biomedical Ltd. (PBM) ESG Analysis Analysis (2026)

Invetso Score: 5.4/10 — Balanced · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Environmental

Score: 5.0 (Moderate)

PBM shows no disclosed R&D intensity in the provided metrics, limiting evidence of environmental innovation versus peers with more explicit decarbonization or product stewardship disclosure.

The absence of reported gross profit margin and FCF margin data constrains assessment of capital available for environmental compliance, leaving its positioning broadly in line with opaque peers.

No direct environmental metrics on emissions, energy use, or waste are provided, so PBM cannot be shown to outperform peers on operational environmental management.

Relative to peers with clearer sustainability reporting, PBM’s environmental profile appears neutral to slightly weaker because disclosure depth is insufficient to evidence stronger positioning.

Social

Score:

PBM provides no disclosed workforce, safety, or human-capital metrics in the supplied data, which weakens comparability against peers with more transparent social reporting.

Zero reported stock-based compensation to revenue may indicate limited equity dilution, but it does not materially evidence stronger employee alignment versus peers.

The lack of disclosed social indicators such as turnover, training, or diversity limits visibility into labor practices, leaving PBM broadly average relative to peers.

Compared with peers that publish richer social KPIs, PBM’s social positioning is constrained by disclosure gaps rather than clear operational underperformance.

Governance

Score:

PBM’s debt-to-equity ratio is reported at zero, which suggests a conservative capital structure relative to leveraged peers and reduces balance-sheet governance risk.

Net debt to EBITDA of 1.08 indicates moderate leverage, positioning PBM better than more indebted peers but not clearly best-in-class on financial discipline.

Zero stock-based compensation to revenue may imply lower compensation complexity than peers with heavier equity awards, modestly supporting governance alignment.

Overall governance appears middling because leverage is manageable, but the provided data do not show the board, audit, or shareholder-rights strengths needed for a stronger peer ranking.

Overall Score

Score:

PBM’s ESG positioning is broadly average versus peers, with modest governance support from manageable leverage but limited disclosure depth across environmental and social factors.

Score Driver: Limited ESG Disclosure Visibility Across Environmental And Social Metrics

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on Psyence Biomedical Ltd.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →